Euclises Pharmaceuticals, Inc. announced it raised $0 in an initial filing from an offering of $663,000
Euclises Pharmaceuticals, Inc. announced it raised $0 in an initial filing from an offering of $663,000
10/01/15, 4:33 PM
Location
missouriMoney raised
$0
Industry
healthcare
Company Info
Company
Euclises Pharmaceuticals, Inc.
Location
missouri, united states
Additional Info
Euclises Pharmaceuticals develops novel COX-2 inhibitors for the effective treatment of cancers in the lungs, colon, and pancreas.